AMPH
$20.86
Amphastar Pharma
$.45
2.20%
AMPH
Earnings Whisper ®
N/A
2nd Quarter June 2021
Consensus:  $0.21
Revenue:  $101.78 Mil
Thursday
Aug 5
4:05 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when AMPH reports earnings?
Beat
Meet
Miss

Where is AMPH's stock price going from here?
Up
Flat
Down
Stock chart of AMPH
Analysts
Summary of analysts' recommendations for AMPH
Score
Grade
Pivots
Resistance
$21.59
$21.23
$21.04

$20.68

Support
$20.49
$20.13
$19.94
Tweet
Growth
Description
Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products. The company products include Enoxaparin Sodium Injection; Amphadase; Cortrosyn for Injection; and prefilled disposable emergency syringes for crash cart use. Amphastar Pharmaceuticals, Inc. is headquartered in Rancho Cucamonga, California.
Peers
Vertex PharmaceuticalsRegeneron PharmaceuticalsBioMarin PharmaceuticalBristol-Myers SquibbInterCeptPfizerUltragenyx PharmaceuticalZoetisMerck & Co.Eli Lilly